These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone. Khan AA; Strawn JR; Croarkin PE Adolesc Health Med Ther; 2010; 1():137-43. PubMed ID: 24600269 [TBL] [Abstract][Full Text] [Related]
4. From clinical research to clinical practice: a 4-year review of ziprasidone. Nemeroff CB; Lieberman JA; Weiden PJ; Harvey PD; Newcomer JW; Schatzberg AF; Kilts CD; Daniel DG CNS Spectr; 2005 Nov; 10(11 Suppl 17):1-20. PubMed ID: 16381088 [TBL] [Abstract][Full Text] [Related]
5. Ziprasidone-associated mania: a case series and review of the mechanism. Baldassano CF; Ballas C; Datto SM; Kim D; Littman L; O'Reardon J; Rynn MA Bipolar Disord; 2003 Feb; 5(1):72-5. PubMed ID: 12656943 [TBL] [Abstract][Full Text] [Related]
6. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Stimmel GL; Gutierrez MA; Lee V Clin Ther; 2002 Jan; 24(1):21-37. PubMed ID: 11833834 [TBL] [Abstract][Full Text] [Related]
8. Ziprasidone in bipolar disorder. Versiani M Expert Opin Pharmacother; 2006 Jun; 7(9):1221-8. PubMed ID: 16732708 [TBL] [Abstract][Full Text] [Related]
9. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review]. Munch G; Godart N Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720 [TBL] [Abstract][Full Text] [Related]
10. Ziprasidone: the fifth atypical antipsychotic. Caley CF; Cooper CK Ann Pharmacother; 2002 May; 36(5):839-51. PubMed ID: 11978164 [TBL] [Abstract][Full Text] [Related]
11. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K; Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364 [TBL] [Abstract][Full Text] [Related]
12. Treatment of bipolar mania with atypical antipsychotics. Chengappa KN; Suppes T; Berk M Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862 [TBL] [Abstract][Full Text] [Related]
13. Ziprasidone in the treatment of affective disorders: a review. Rosa AR; Franco C; Torrent C; Comes M; Cruz N; Horga G; Benabarre A; Vieta E CNS Neurosci Ther; 2008; 14(4):278-86. PubMed ID: 19040553 [TBL] [Abstract][Full Text] [Related]
14. Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia. Gao K; Pappadopulos E; Karayal ON; Kolluri S; Calabrese JR J Clin Psychopharmacol; 2013 Jun; 33(3):425-31. PubMed ID: 23609405 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic agents in the treatment of bipolar mania. Tohen M; Vieta E Bipolar Disord; 2009 Jun; 11 Suppl 2():45-54. PubMed ID: 19538685 [TBL] [Abstract][Full Text] [Related]
16. Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials. Greenberg WM; Citrome L CNS Drug Rev; 2007; 13(2):137-77. PubMed ID: 17627670 [TBL] [Abstract][Full Text] [Related]
17. Acute treatment of mania: an update on new medications. Gajwani P; Kemp DE; Muzina DJ; Xia G; Gao K; Calabrese JR Curr Psychiatry Rep; 2006 Dec; 8(6):504-9. PubMed ID: 17094930 [TBL] [Abstract][Full Text] [Related]
18. Ziprasidone-associated mania: a review and report of 2 additional cases. Keating AM; Aoun SL; Dean CE Clin Neuropharmacol; 2005; 28(2):83-6. PubMed ID: 15795551 [TBL] [Abstract][Full Text] [Related]
19. 26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic). Atkinson S; Bachinsky M; Raiter Y; Abreu P; Ianos C; Chappell P; Findling RL J Child Adolesc Psychopharmacol; 2022 Oct; 32(8):453-458. PubMed ID: 36282771 [No Abstract] [Full Text] [Related]